Cell Therapy Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Published Date : Mar 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Cell Therapy Market, By Use-type

7.1.  Cell Therapy Market, By Use-type Type, 2020-2030

7.1.1.    Clinical-use

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Research-use

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Cell Therapy Market, By Therapy Type

8.1.  Cell Therapy Market, By Therapy Type, 2020-2030

8.1.1.    Allogenic Therapies

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Autologous Therapies

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Cell Therapy Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Use-type (2016-2030)

9.1.2.    Market Revenue and Forecast, By Therapy Type (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.1.3.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.1.4.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Use-type (2016-2030)

9.2.2.    Market Revenue and Forecast, By Therapy Type (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.2.3.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.2.4.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.2.5.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.2.6.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Use-type (2016-2030)

9.3.2.    Market Revenue and Forecast, By Therapy Type (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.3.3.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.3.4.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.3.5.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.3.6.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Use-type (2016-2030)

9.4.2.    Market Revenue and Forecast, By Therapy Type (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.4.3.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.4.4.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.4.5.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.4.6.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Use-type (2016-2030)

9.5.2.    Market Revenue and Forecast, By Therapy Type (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.5.3.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Use-type (2016-2030)

9.5.4.2.        Market Revenue and Forecast, By Therapy Type (2016-2030)

Chapter 10.  Company Profiles

10.1.              Kolon TissueGene, Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Anterogen Co., Ltd.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              JCR Pharmaceuticals Co., Ltd.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Castle Creek Biosciences, Inc.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              The Future of Biotechnology, MEDIPOST

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Osiris Therapeutics, Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              PHARMICELL Co., Ltd

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Tameika Cell Technologies, Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Cells for Cells

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           NuVasive, Inc.

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.11.           Vericel Corporation

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.12.           Celgene Corporation

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Tracheostomy Products Market (By Demographics: Adults, Paediatrics/Neonatal; By Type: Tracheostomy Tubes, Ventilation Accessories ; By Technique; By End Use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Smart Blood Pressure Monitoring Devices Market (By Type: Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor Finger Blood Pressure Monitor; By Technology: Wi-Fi Based/4G, Bluetooth Based)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Laparoscopic Electrodes Market (By Application: Bariatric, General Surgeries; By Product: Monopolar, Bipolar Electrodes; By End User: Hospital, Ambulatory)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Virtual Visits Market (By Service Type: Cold & Flu management, Allergies, Urgent Care, Preventive Care, Chronic Care Management, Behavioural Health ; By Commercial Plan Type: Small Group, Self-Funded/ASO Group Plans, Medicaid, Medicare, By Age Group, By Gender)- Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Next-Generation Sequencing Services Market (By Service Type: Human Genome Sequencing, Gene Regulation Services; By Workflow: Pre-sequencing, Sequencing, Data Analysis; By End-use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...